Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients
Thoracic Cancer · 2024
DOI: 10.1111/1759-7714.15202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Xiang Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
This study aimed to investigate the clinicopathological features and prognostic indicators of primary pulmonary adenoid cystic carcinoma (PACC).
Methods
Clinical data were collected from 64 primary PACC patients and analyzed retrospectively at the Tianjin Medical University General Hospital, the West China Hospital of Sichuan University, the First Affiliated Hospital of Guangxi Medical University, and the Bishan Hospital of Chongqing Medical University from January 2003 to August 2023. The 64 patients (28 males and 36 females) were aged from 20 to 73 years, with a median age of 49 years and an average age of 49.3 years.
Results
Immunohistochemical staining showed that the tumors expressed CK7, S‐100 protein, CK5/6, CD117, and p63. Seven patients underwent fluorescence in situ hybridization (FISH) testing and three were found to have myeloblastosis (MYB) gene translocation. In total, 53 patients underwent surgery, among whom 31 received only surgery and 22 received both surgery and postoperative chemoradiotherapy. In addition, 10 patients received chemoradiotherapy only, while one patient underwent treatment with traditional Chinese medicine. The overall survival rates in the first, third, and fifth years were 98.4%, 95.3%, and 87.5%, respectively.
Conclusion
Prognostic analysis revealed that age, tumor size, lymph node metastasis status, margin status, and choice of treatment modality significantly influenced the patients' prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
- Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Thoracic Surgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Lung Cancer Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.
- Department of Cardiothoracic Surgery, Bishan Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Wang Shen, Xiaojun Tang
Zitieren
APA
Tan, X., Xu, T., Shen, W., Ai, C., Zhang, W., Tang, X., Luo, F., & Zhou, Q. (2024). Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15202
Vancouver
Tan X, Xu T, Shen W, Ai C, Zhang W, Tang X, et al. Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15202
BibTeX
@article{Tan2024,
author = {Tan, Xiang and Xu, Tao and Shen, Wang and Ai, Cheng and Zhang, Weilin and Tang, Xiaojun and Luo, Feng and Zhou, Qinghua},
title = {Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients},
journal = {Thoracic Cancer},
year = {2024},
doi = {10.1111/1759-7714.15202}
}
EUVIMED